基于参考计划和统计模型的腔内甲基疗法的独立验证系统
Yuichi Akino1, Fumiaki Isohashi1,2, Takehiro Arimura3
1Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Journal of radiation research
|March 5, 2025
概括
在宫癌治疗中开发了一种新的高剂量率 (HDR) 内腔支臂疗法 (ICBT) 验证系统. 该系统准确地预测停留时间并检测人为错误,提高各种技术和后载机的处理安全性.
科学领域:
- 医学物理 医学物理
- 辐射瘤学 辐射瘤学
- 在瘤学瘤学.
背景情况:
- 高剂量率 (HDR) 腔内支臂疗法 (ICBT) 对于宫癌治疗至关重要.
- 远程后载系统是现代ICBT交付不可或缺的一部分.
- 确保治疗规划的准确性和安全性至关重要.
研究的目的:
- 开发和评估ICBT临床计划的新型验证系统.
- 评估系统在不同远程后装载器,应用器和技术中的可行性.
- 为了提高宫癌支臂治疗的安全性和可靠性.
主要方法:
- 为517个临床计划 (PlanClin) 创建了参考计划 (PlanRef).
- 开发了一个与V100%和总停留时间 (Tdwell) 相关联的方程.
- 创建了软件,通过比较PlanClin与PlanRef参数来检测人类错误.
主要成果:
- 在V100%和Tdwell之间发现了强烈的相关性,使得准确的Tdwell预测.
- 开发的方程以高精度 (0.26 ± 0.49%) 估计了Flexitron后装计划的Tdwell.
- 该系统成功地识别了治疗计划中的各种引入的人类错误.
结论:
- 开发的验证系统,利用PlanRef和统计分析,可用于各种ICBT设置.
- 该系统支持安全实施宫癌支臂疗法.
- 这种方法提高了HDR-ICBT的质量保证.
相关概念视频
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
727
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
727
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
426
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
426


